Vertex Dips on Mixed Phase II Data for Non-Opioid Pain Therapy
Vertex Pharmaceuticals on Thursday released mid-stage data for its investigational non-opioid analgesic suzetrigine, which elicited significant pain relief from baseline—but failed to significantly outperform placebo. Investors were underwhelmed by the …